
| Salt Composition: | Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg) |
| Manufacturer: | Aster Medipharm Pvt Ltd |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Voglicose GM 2mg/500mg/0.3mg Tablet is an anti-diabetic drug used to treat type 2 diabetes mellitus in adults by controlling blood sugar levels. Voglicose GM 2mg/500mg/0.3mg Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes. The medicine should be taken with food to avoid an upset stomach and can cause hypoglycemia when used with other antidiabetic medicines, alcohol, or if a meal is delayed or missed. Regular liver function checks are recommended, and any symptoms such as abdominal pain, loss of appetite, or jaundice should be reported to a doctor.
Voglicose GM 2mg/500mg/0.3mg Tablet is a combination of three antidiabetic medicines.
What is Voglicose GM 2mg/500mg/0.3mg Tablet?
Voglicose GM 2mg/500mg/0.3mg Tablet is a combination of three medicines: Glimepiride, Metformin and Voglibose. This medication is prescribed for the treatment of type 2 diabetes mellitus (DM). It improves blood glucose levels in adults when taken alongside a balanced diet and regular exercise. Glimepiride lowers blood glucose by increasing insulin release from the pancreas. Metformin decreases glucose production by the liver and enhances insulin sensitivity. Voglibose acts as an alpha-glucosidase inhibitor, lowering postprandial (after meals) glucose levels.
What are possible side effects of Voglicose GM 2mg/500mg/0.3mg Tablet?
Common side effects associated with Voglicose GM 2mg/500mg/0.3mg Tablet include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infection.
In what specific circumstances should I avoid taking Voglicose GM 2mg/500mg/0.3mg Tablet?
It is essential to refrain from using this medication in patients with known allergies to any of the components or excipients. Additionally, avoid its usage in individuals with moderate to severe kidney disease and inflammatory bowel diseases such as ulcerative colitis or Crohn's disease. The use of Voglicose GM 2mg/500mg/0.3mg Tablet is also not recommended if there is a history of metabolic acidosis, including diabetic ketoacidosis.
Is it safe to consume alcohol while taking Voglicose GM 2mg/500mg/0.3mg Tablet?
No, combining alcohol with Voglicose GM 2mg/500mg/0.3mg Tablet is not advised. It can lower your blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Can the use of Voglicose GM 2mg/500mg/0.3mg Tablet cause hypoglycemia?
Yes, the use of Voglicose GM 2mg/500mg/0.3mg Tablet can lead to hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate and feelings of anxiety or shakiness. It is more likely to occur if you miss meals or snacks, drink alcohol, exercise excessively, or take other antidiabetic medications simultaneously.
What are the storage and disposal instructions for Voglicose GM 2mg/500mg/0.3mg Tablet?
Store this medication in its original packaging, tightly closed. Follow the storage instructions provided on the package or label. Dispose of unused medication. Ensure that it is not accessible to pets, children, and other individuals.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Voglicose GM 2mg/500mg/0.3mg Tablet is to be taken on an empty stomach.
Alcohol
It is unsafe to consume alcohol with Voglicose GM 2mg/500mg/0.3mg Tablet.
Breastfeed
Voglicose GM 2mg/500mg/0.3mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnancy
Voglicose GM 2mg/500mg/0.3mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Please consult your doctor.